Ixazomib Benefit Persists Despite Prior Therapy in TOURMALINE-MM1 Subset Analysis
Recent Articles
Senator Pushes Pfizer to Permanently Roll Back Prices
U.S. Senator Tammy Baldwin (D-WI) has written to Pfizer CEO Ian Read asking the company to “permanently roll back” the prices for its prescription...
CMS Proposes Reimbursing Doctors for Telehealth
The Centers for Medicare and Medicaid Services (CMS) has proposed the first major overhaul of Medicare billing practices since 1995. Under the new rules,...
FDA Approves Freeze-Dried Plasma in Combat
The U.S. Food and Drug Administration (FDA) has approved the use of freeze-dried plasma for use by the U.S military. This emergency authorization, requested...
FDA Considering Use of Off-Label Data for Drug Approvals
The U.S. Food and Drug Administration (FDA) signaled its willingness this month to use off-label information in approving new indications for drugs in the...
Trump Administration Cuts Funding for ACA Navigators
The Centers for Medicare and Medicaid Services (CMS) has announced that it will cut funding for “navigator” organizations that help Americans shop for and...
Current Issue
July 2018 Bonus Mid-Year Edition
This bonus issue features a look at the most recent changes to Maintenance of Certification programs, highlights from recent hematology/oncology meetings, and more.
